Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009

Links shared publicly online about this topic.

  • 1,263
    total visits

Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009

news-medical.net —

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.

View full resource at news-medical.net

Tags: Pharma, Oncology

  • Share

Most Recently Shared on April 5, 2010 at 1:07 pm By:

Oncology_News News-Medical.Net

Oncology News: Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009: Spectrum Pharmaceutical... http://bit.ly/bj3Y4Z

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

News-Medical.Net News-Medical.Net

Advertisement